AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11782042
Drug: Marginal models
RxNorm normalized name: Culex marginalis
DrugBank: Culex pipiens (DB14165)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marginal models (GEE, WGEE, ML)
Trial: 9059684
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg terbinafine daily for 3 months
Trial: 9059684
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg terbinafine daily for 3 or 6 months
Trial: 8112373
Drug: Nicorandil (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (all doses)
Trial: 2873000
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with theophylline and beta-adrenergic agonist
Trial: 25709055
Drug: Self-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-guided therapy
Trial: 28060048
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of inactivated hepatitis A vaccine (group 1)
Trial: 28060048
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of inactivated hepatitis A vaccine plus 1 dose of combined hepatitis A and B vaccine (group 2)
Trial: 28060048
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of combined hepatitis A and B vaccine (group 3)
Trial: 25454689
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 12 mg I.V. ibandronate on day 1 then oral ibandronate 50 mg daily (arm A)
Trial: 25454689
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral therapy of 50 mg ibandronate daily from day 1 (arm B)
Trial: 25454689
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 12 mg I.V. ibandronate (arm A)
Trial: 23062542
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) with an implantable cardioverter‐defibrillator (ICD)
Trial: 15774402
Drug: Green land-based
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Green land-based activities, training and social support; specific dosage and duration not mentioned.
Trial: 15774402
Drug: Qualitative interviews
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qualitative interviews and focus group discussions; specific dosage and duration not mentioned.
Trial: 9670112
Drug: Training group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training group (n = 21) - physical training including exercises on bicycle ergometer for 30 minutes (5 times a week), overall-conditioning exercises for 30 minutes daily, and 30 to 60 minutes of walking each day.
Trial: 8152756
Drug: Powder-free surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powder-free surgical gloves with postoperative injections of 5-fluorouracil
Trial: 3062134
Drug: Azathioprine in
RxNorm normalized name: azathioprine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine in combination with steroids
Trial: 19404953
Drug: Azathioprine treatment
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine treatment
Trial: 11579006
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care integrated with motivational interviewing, cognitive behavior therapy, and family intervention
Trial: 8129387
Drug: 1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day CGS16949A
Trial: 8129387
Drug: 2 mg/day
RxNorm normalized name: Neupro 2 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/day CGS16949A
Trial: 8129387
Drug: 4 mg/day
RxNorm normalized name: Neupro 4 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg/day CGS16949A
Trial: 30453316
Drug: Treatment condition
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment condition (Sketch and Speak intervention)
Trial: 26079469
Drug: Immediate insertion
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate insertion of contraceptive implant
Trial: 26079469
Drug: Delayed insertion
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed insertion of contraceptive implant
Trial: 23561463
Drug: Practical prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practical prescription information or services
Trial: 23561463
Drug: Combination prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination prescription information or services
Trial: 23561463
Drug: Practical prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practical prescription information or services (for subjects prescribed a drug that treats an underlying condition)
Trial: 11579011
Drug: Pindolol 5
RxNorm normalized name: pindolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 5 mg t.i.d. for 4 weeks
Trial: 9649259
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg testosterone via intramuscular injection once a week for 15 weeks
Trial: 9649259
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg testosterone via intramuscular injection once a week for 15 weeks
Trial: 9649259
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg testosterone via intramuscular injection once a week for 15 weeks
Trial: 9649259
Drug: Total semen
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total semen PSA levels decreased following administration of testosterone
Trial: 31401679
Drug: Cod intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cod intake (750 g/week for 8 weeks)
Trial: 31401679
Drug: Salmon intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon intake (750 g/week for 8 weeks)
Trial: 30935953
Drug: R-pina (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-pina (375 mg/m2 rituximab plus 2.4 mg/kg pinatuzumab vedotin)
Trial: 30935953
Drug: R-pola (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-pola (375 mg/m2 rituximab plus 2.4 mg/kg polatuzumab vedotin)
Trial: 28077162
Drug: Fixed inhaled
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed inhaled nitrous oxide/oxygen mixture
Trial: 28077162
Drug: Standard pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pain treatment (oral immediate-release morphine) plus nitrous oxide/oxygen mixture
Trial: 28077162
Drug: Standard pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pain treatment (oral immediate-release morphine) plus oxygen
Trial: 23718718
Drug: Varenicline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline plus nicotine patch (15 mg/16 hour)
Trial: 23718718
Drug: Varenicline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline plus placebo patch
Trial: 23718718
Drug: Varenicline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline plus nicotine patch
Trial: 7930412
Drug: Valproate treatment
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproate treatment
Trial: 18955565
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy (HDT) followed by autologous purged stem cell transplantation (ASCT)
Trial: 11915269
Drug: Wheelchair biking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheelchair biking therapy for 2 weeks
Trial: 356707
Drug: Diazepam (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.2 mg/kg)
Trial: 7982137
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Vecuronium 0.1 mg/kg without diazepam)
Trial: 807170
Drug: Parenteral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral fat free nutrition (primary caloric source glucose)
Trial: 30228338
Drug: Sequential seeding
RxNorm normalized name: Plantago Seed
DrugBank: Plantago seed (DB11097)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential seeding
Trial: 23201472
Drug: GM+G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM+G-CSF
Trial: 16555172
Drug: Non-pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological treatment (NPT)
Trial: 26272687
Drug: Intravaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal misoprostol (200 μg)
Trial: 25170230
Drug: Furazolidone-based triple
RxNorm normalized name: Furazolidone
DrugBank: Furazolidone (DB00614)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furazolidone-based triple therapy (rabeprazole 10 mg, amoxicillin 1000 mg, furazolidone 100 mg) for 7 days
Trial: 25170230
Drug: Furazolidone-based quadruple
RxNorm normalized name: Furazolidone
DrugBank: Furazolidone (DB00614)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furazolidone-based quadruple therapy (rabeprazole 10 mg, bismuth 220 mg, amoxicillin 1000 mg, furazolidone 100 mg) for 7 days
Trial: 25170230
Drug: Furazolidone-based triple
RxNorm normalized name: Furazolidone
DrugBank: Furazolidone (DB00614)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furazolidone-based triple therapy (rabeprazole 10 mg, amoxicillin 1000 mg, furazolidone 100 mg) for 10 days
Trial: 25170230
Drug: Furazolidone-based quadruple
RxNorm normalized name: Furazolidone
DrugBank: Furazolidone (DB00614)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furazolidone-based quadruple therapy (rabeprazole 10 mg, bismuth 220 mg, amoxicillin 1000 mg, furazolidone 100 mg) for 10 days
Trial: 23176379
Drug: Allicor (time-released
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allicor (time-released garlic-based drug)
Trial: 20581879
Drug: Late mRNA-based
RxNorm normalized name: mRNA-3705
DrugBank: mRNA-3705 (DB17668)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late mRNA-based (NucliSens CMV pp67) anti-HCMV treatment
Trial: 20581879
Drug: PCR-based preemptive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCR-based preemptive HCMV-directed antiviral therapy
Trial: 20581879
Drug: Both late
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both late mRNA-based and PCR-based therapies
Trial: 18463998
Drug: Psychosocial treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial treatments (four types) for cocaine dependence
Trial: 18463998
Drug: Non-protocol services
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-protocol services (additional treatment services)
Trial: 10731499
Drug: Strontium with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strontium with 35 g lactose (load B)
Trial: 10731499
Drug: Strontium with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strontium with 17.5 g glucose and 17.5 g galactose (load C)
Trial: 8941092
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin infusion (250 IU primed, 600 IU/h continuous)
Trial: 8941092
Drug: Heparin/insulin period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin/insulin period
Trial: 2060541
Drug: Glipizide 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide 0.5 mg
Trial: 2060541
Drug: Glipizide 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide 1.0 mg
Trial: 2060541
Drug: Glipizide 2.5
RxNorm normalized name: glipizide 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide 2.5 mg
Trial: 29577536
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump therapy (control)
Trial: 23924302
Drug: Multifaceted intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multifaceted intervention including universal nutritional screening, oral nutritional supplements, red trays, and additional feeding support
Trial: 16137945
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 1,200-1,500 mg/day (WHO, North America, Europe)
Trial: 16137945
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 800 mg/day (Japan)
Trial: 8725991
Drug: Risperidone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (6 mg)
Trial: 12900301
Drug: Risperidone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (6 mg) with enhanced community-based skills training
Trial: 12900301
Drug: Haloperidol (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (low dose)
Trial: 10469192
Drug: Omeprazole, 20
RxNorm normalized name: Omeprazole, 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, 20 mg twice daily, plus amoxicillin, 1 gm twice daily, and clarithromycin, 500 mg twice daily for 10 days
Trial: 10469192
Drug: Pantoprazole, 40
RxNorm normalized name: Pantoprazole, 40 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole, 40 mg daily, plus amoxicillin and clarithromycin at the same doses as those of group Ome40
Trial: 10469192
Drug: Pantoprazole, 40
RxNorm normalized name: Pantoprazole, 40 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole, 40 mg twice daily, plus amoxicillin and clarithromycin at the same doses as those of group Ome40
Trial: 6366560
Drug: Symptomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatment only (Control)
Trial: 30860603
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) alcohol to a target breath alcohol concentration (BrAC) of 0.06 g/dl
Trial: 19200175
Drug: APL 200
RxNorm normalized name: APL-502
DrugBank: APL-502 (DB17473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APL 200 mg bid
Trial: 19200175
Drug: APL 400
RxNorm normalized name: APL-502
DrugBank: APL-502 (DB17473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APL 400 mg bid
Trial: 19200175
Drug: APL 800
RxNorm normalized name: APL-502
DrugBank: APL-502 (DB17473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APL 800 mg qd
Trial: 9037327
Drug: Mibefradil 50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mibefradil 50, 100, and 150 mg
Trial: 9037327
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30, 60, and 90 mg
Trial: 9037327
Drug: Mibefradil 150
RxNorm normalized name: mibefradil
DrugBank: Mibefradil (DB01388)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mibefradil 150 mg alone or combined with lisinopril 20 mg
Trial: 2883695
Drug: Lorazepam (0.057
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (0.057 mg/kg)
Trial: 2883695
Drug: Alprazolam (0.029
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.029 mg/kg)
Trial: 2883695
Drug: Diazepam (0.286
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.286 mg/kg)
Trial: 2883695
Drug: Placebo (0.000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.000 mg/kg)
Trial: 2883695
Drug: Lorazepam (0.028
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (0.028 mg/kg)
Trial: 2883695
Drug: Alprazolam (0.014
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.014 mg/kg)
Trial: 2883695
Drug: Diazepam (0.143
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.143 mg/kg)
Trial: 24911577
Drug: Lorediplon 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorediplon 5 mg
Trial: 24911577
Drug: Lorediplon 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorediplon 10 mg
Trial: 24911577
Drug: Lorediplon 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorediplon 1 mg
Trial: 22350925
Drug: Zolpidem 10
RxNorm normalized name: zolpidem 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 10 mg (active control)
Trial: 22419350
Drug: POIO (preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: POIO (preoperative and intraoperative dose)
Trial: 22419350
Drug: POIOPO (preoperative,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: POIOPO (preoperative, intraoperative, and postoperative doses)
Trial: 22419350
Drug: IO (intraoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IO (intraoperative dose only)
Trial: 22419350
Drug: IOPO (intraoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IOPO (intraoperative and postoperative doses)
Trial: 20804368
Drug: Cs-4 (Cordyceps
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cs-4 (Cordyceps sinensis) 333 mg, taken 3 times a day for 12 weeks
Trial: 18000183
Drug: Coccinia cordifolia
RxNorm normalized name: Coccinia grandis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coccinia cordifolia extract (1 g alcoholic extract for 90 days)
Trial: 15930077
Drug: Dialectical behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialectical behavior therapy plus olanzapine (mean dose 8.83 mg/day)
Trial: 15930077
Drug: Dialectical behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialectical behavior therapy plus placebo
Trial: 10584567
Drug: MPA 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA 1,200 mg
Trial: 10584567
Drug: MPA 600
RxNorm normalized name: MPA
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA 600 mg
Trial: 6863091
Drug: Caffeine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (500 mg) administered orally
Trial: 29020589
Drug: ChAd3‐EBO‐Z vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ChAd3‐EBO‐Z vaccine
Trial: 29020589
Drug: rVSV∆G‐ZEBOV‐GP vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rVSV∆G‐ZEBOV‐GP vaccine
Trial: 23431996
Drug: ATG-Fresenius (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATG-Fresenius (9 mg/kg body weight)
Trial: 17580147
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no induction therapy)
Trial: 19584690
Drug: Everolimus with
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus with reduced cyclosporine A (CsA) (trough level 3-8 ng/mL)
Trial: 19584690
Drug: MMF (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF (3 g/day) with standard CsA
Trial: 12514304
Drug: CLA-mix (8.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLA-mix (8.0 g daily, 76% pure CLA)
Trial: 12514304
Drug: Safflower oil
RxNorm normalized name: Safflower Oil
DrugBank: Safflower oil (DB09446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safflower oil (placebo, 8.0 g daily)
Trial: 8762417
Drug: Zhikang Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhikang Oral Liquid (ZK)
Trial: 7751430
Drug: Bisoprolol 5
RxNorm normalized name: bisoprolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 5 mg (B5)
Trial: 1676675
Drug: Bisoprolol 10
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 10 mg (B10)
Trial: 1676675
Drug: Bisoprolol 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 20 mg (B20)
Trial: 1676675
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg (A100)
Trial: 1676675
Drug: Nadolol 40
RxNorm normalized name: nadolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 40 mg (N40)
Trial: 27007998
Drug: Ambroxol oral
RxNorm normalized name: ambroxol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol oral tablets
Trial: 27007998
Drug: Ambroxol orally-disintegrating
RxNorm normalized name: ambroxol
DrugBank: Ambroxol (DB06742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol orally-disintegrating tablets
Trial: 24035344
Drug: Ketamine 0.41
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.41 mg/kg
Trial: 24035344
Drug: Ketamine 0.71
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.71 mg/kg
Trial: 17414939
Drug: Pramipexole (0.375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole (0.375 mg/d to a maximum tolerated dose of ≤4.5 mg/d over a 6-week period)
Trial: 15708053
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (100 mg) taken 1 to 2 hours before VCD use
Trial: 15708053
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (sildenafil + VCD)
Trial: 12218949
Drug: Heparin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (100 IU/kg body weight, subcutaneous for 6 days)
Trial: 9593384
Drug: Heparin surface-modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin surface-modified (HSM) intraocular lenses (IOLs)